Your browser is no longer supported. Please, upgrade your browser.
HROW [NASD]
Harrow Health, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own0.40% Shs Outstand27.11M Perf Week-17.17%
Market Cap195.75M Forward P/E19.88 EPS next Y0.35 Insider Trans- Shs Float24.09M Perf Month-21.86%
Income-9.90M PEG- EPS next Q-0.04 Inst Own55.20% Short Float3.87% Perf Quarter-27.75%
Sales66.90M P/S2.93 EPS this Y-238.50% Inst Trans0.19% Short Ratio8.99 Perf Half Y-25.89%
Book/sh0.61 P/B11.31 EPS next Y179.50% ROA-12.30% Target Price16.12 Perf Year-25.61%
Cash/sh2.39 P/C2.89 EPS next 5Y15.00% ROE-41.60% 52W Range6.00 - 12.99 Perf YTD-20.14%
Dividend- P/FCF45.52 EPS past 5Y40.00% ROI0.70% 52W High-46.88% Beta0.88
Dividend %- Quick Ratio8.30 Sales past 5Y38.10% Gross Margin74.50% 52W Low15.00% ATR0.43
Employees125 Current Ratio8.70 Sales Q/Q29.90% Oper. Margin10.50% RSI (14)19.92 Volatility7.32% 5.14%
OptionableYes Debt/Eq4.31 EPS Q/Q-196.30% Profit Margin-14.80% Rel Volume1.60 Prev Close7.43
ShortableYes LT Debt/Eq4.31 EarningsNov 09 AMC Payout- Avg Volume103.65K Price6.90
Recom1.70 SMA20-16.28% SMA50-23.85% SMA200-24.71% Volume165,611 Change-7.07%
Oct-14-21Resumed B. Riley Securities Buy $16
Sep-24-21Initiated Aegis Capital Buy $15
Jul-02-21Initiated Ladenburg Thalmann Buy $14.25
Jan-10-22 06:45AM  
Jan-04-22 08:00AM  
Dec-30-21 10:24AM  
Dec-20-21 07:00AM  
Dec-13-21 08:00AM  
Dec-07-21 04:32PM  
Dec-06-21 11:54AM  
Nov-29-21 10:00AM  
Nov-19-21 12:20PM  
Nov-09-21 06:25PM  
04:01PM  
Nov-07-21 08:53AM  
Oct-25-21 09:00AM  
Sep-27-21 08:26AM  
Sep-02-21 08:00AM  
Aug-18-21 07:00AM  
Aug-13-21 01:21AM  
Aug-12-21 12:45PM  
07:45AM  
Aug-10-21 05:15PM  
04:01PM  
Aug-05-21 10:57AM  
Aug-03-21 03:01PM  
05:07AM  
Aug-02-21 05:50PM  
Jul-28-21 11:30AM  
Jul-27-21 07:00AM  
Jul-26-21 09:00AM  
Jul-19-21 08:00AM  
Jul-16-21 10:00AM  
Jul-15-21 08:00AM  
Jul-06-21 08:27AM  
Jun-23-21 06:34AM  
Jun-17-21 04:01PM  
Jun-14-21 05:59PM  
07:45AM  
Jun-04-21 04:03AM  
Jun-03-21 08:15AM  
Jun-01-21 09:00AM  
May-17-21 09:00AM  
May-11-21 04:01PM  
02:45PM  
May-05-21 04:03PM  
04:01PM  
May-04-21 03:00PM  
Apr-27-21 09:00AM  
Apr-20-21 04:01PM  
Apr-15-21 05:00PM  
Apr-14-21 04:01PM  
04:00PM  
Apr-05-21 05:43AM  
Mar-11-21 09:45AM  
Mar-08-21 06:05PM  
04:01PM  
01:45PM  
Mar-02-21 09:00AM  
Mar-01-21 04:26PM  
Feb-25-21 09:00AM  
Feb-09-21 07:00AM  
Feb-04-21 02:25AM  
Dec-18-20 11:22AM  
Dec-17-20 10:30AM  
Dec-15-20 10:30PM  
Dec-08-20 08:33AM  
Dec-03-20 07:30AM  
Nov-20-20 07:30AM  
Nov-09-20 05:35PM  
04:01PM  
02:45PM  
Nov-06-20 10:21AM  
08:52AM  
Nov-02-20 12:31PM  
Oct-27-20 07:30AM  
05:46AM  
Sep-30-20 08:00AM  
Sep-16-20 08:36AM  
Sep-11-20 11:22AM  
Sep-07-20 03:03PM  
Aug-26-20 08:16AM  
Aug-10-20 08:05PM  
04:00PM  
Aug-07-20 11:05AM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-27-20 07:30AM  
Jul-24-20 10:24AM  
Jul-13-20 07:30AM  
Jun-30-20 11:57PM  
Jun-29-20 07:30AM  
Jun-24-20 08:30AM  
Jun-18-20 07:30AM  
May-14-20 08:40AM  
May-11-20 06:55PM  
04:01PM  
May-05-20 08:52AM  
Apr-27-20 07:30AM  
Mar-24-20 07:30AM  
Mar-17-20 07:30AM  
Mar-13-20 11:15AM  
07:31AM  
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUM MARK LChief Executive OfficerJan 20Option Exercise2.40125,000300,0001,478,547Jan 21 08:45 PM
LINDSTROM RICHARD L MDDirectorSep 24Sale10.043,90039,15666,100Sep 27 07:31 PM
LINDSTROM RICHARD L MDDirectorSep 16Sale9.025,84052,67770,000Sep 17 05:15 PM
LINDSTROM RICHARD L MDDirectorSep 15Sale9.0914,160128,71475,840Sep 17 05:15 PM
Opaleye Management Inc.10% OwnerAug 19Buy8.4552,500443,3623,135,000Aug 23 05:59 PM
Opaleye Management Inc.10% OwnerAug 18Buy8.6446,500401,9793,085,000Aug 19 07:10 PM
Opaleye Management Inc.10% OwnerAug 17Buy8.5726,000222,7193,040,000Aug 19 07:10 PM
Opaleye Management Inc.10% OwnerJul 21Buy7.609,20669,9333,015,000Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJul 20Buy7.204,92535,4603,010,500Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJul 19Buy6.975,86940,8973,005,700Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJun 18Buy8.3563,322528,6883,000,000Jun 22 11:44 AM
Opaleye Management Inc.10% OwnerJun 17Buy8.3211,26293,7012,940,200Jun 22 11:44 AM
LINDSTROM RICHARD L MDDirectorMay 20Sale10.7510,000107,50090,000May 21 05:28 PM
BOLL ANDREW R.Chief Financial OfficerApr 25Option Exercise0.00127,5000273,000Apr 27 05:30 PM
BAUM MARK LChief Executive OfficerApr 25Option Exercise0.00850,00001,687,676Apr 27 05:29 PM